Clinical Trial Update: A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study exploring donafenib in combination with KN046 for advanced gastrointestinal tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Tumors

Drugs mentioned

• Donafenib (donafenib)
• KN046

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Advanced Gastrointestinal Tumors | Phase 1, Phase 2 | Status: UNKNOWN